Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Surgery
Volume 2018, Article ID 6145903, 4 pages
https://doi.org/10.1155/2018/6145903
Case Report

Granulomatosis with Polyangiitis Localized in the Greater Omentum

1Department of Gastroenterological Surgery, Mitsui Memorial Hospital, Tokyo, Japan
2Department of Pathology, Mitsui Memorial Hospital, Tokyo, Japan

Correspondence should be addressed to Ryuji Komine; moc.liamg@kr.dem.arod

Received 18 December 2017; Accepted 8 February 2018; Published 28 February 2018

Academic Editor: Tahsin Colak

Copyright © 2018 Ryuji Komine et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. Jennette and R. J. Falk, “Small-vessel vasculitis,” New England Journal of Medicine, vol. 337, no. 21, pp. 1512–1523, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. S. J. Haworth and C. D. Pusey, “Severe intestinal involvement in Wegener’s granulomatosis,” Gut, vol. 25, no. 11, pp. 1296–1300, 1984. View at Publisher · View at Google Scholar
  3. B. Storesund, J. T. T. Gran, and W. Koldingsnes, “Severe intestinal involvement in Wegener’s granulomatosis: report of two cases and review of the literature,” British Journal Rheumatology, vol. 37, no. 4, pp. 387–390, 1998. View at Publisher · View at Google Scholar
  4. I. A. Srouji, P. Andrews, C. Edwards, and V. J. Lund, “Patterns of presentation and diagnosis of patients with Wegener’s granulomatosis, ENT aspects,” Journal of Laryngology & Otology, vol. 121, no. 7, pp. 653–658, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. N. I. Abdou, G. J. Kullman, G. S. Hoffman, G. C. Sharp, U. Specks, and T. McDonald, “Wegener’s granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s,” Journal of Rheumatology, vol. 29, no. 2, pp. 309–316, 2002. View at Google Scholar
  6. J. Land, W. H. Abdulahad, S. Arends, J. F. Sanders, A. Stegeman, and P. Heeringa, “Prospective monitoring of in vitro produced PR3-ANCA does not improve relapse prediction in granulomatosis with polyangiitis,” PLoS One, vol. 12, no. 8, Article ID e0182549, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. C. G. M. Kallenberg, “Key advances in the clinical approach to ANCA-associated vasculitis,” Nature Reviews Rheumatology, vol. 10, no. 8, pp. 484–493, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. E.W. Walton, “Giant-cell granuloma of the respiratory tract (Wegener’s granulomatosis),” British Medical Journal, vol. 2, no. 5091, pp. 265–270, 1958. View at Publisher · View at Google Scholar · View at Scopus
  9. O. R. Sipahi, S. Senol, T. Yamazhan et al., “Pooled analysis of 857 published adult fever of unknown origin cases in Turkey between 1990–2006,” Medical Science Monitor, vol. 13, no. 7, p. CR318-322, 2007. View at Google Scholar
  10. L. Guillevin, B. Durand-Gasselin, R. Cevallos et al., “Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients,” Arthritis & Rheumatism, vol. 42, no. 3, pp. 421–430, 1999. View at Publisher · View at Google Scholar
  11. J. D. Finkielman, A. S. Lee, A. M. Hummel et al., “ANCA are detectable in nearly all patients with active severe Wegener’s granulomatosis,” American Journal of Medicine, vol. 120, no. 7, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Wojciechowska, W. Krajewski, P. Krajewski, and T. Kręcicki, “Granulomatosis with polyangiitis in otolaryngologist practice: a review of current knowledge,” Clinical and Experimental Otorhinolaryngology, vol. 9, no. 1, pp. 8–13, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. K. de Groot, D. K. Schmidt, A. C. Arlt, W. L. Gross, and E. Reinhold-Keller, “Standardized neurologic evaluations of 128 patients with Wegener’s granulomatosis,” Archives of Neurology, vol. 58, no. 8, pp. 1215–1221, 2001. View at Publisher · View at Google Scholar
  14. J. U. Holle, W. L. Gross, K. Holl-Ulrich et al., “Prospective long-term follow-up of patients with localized Wegener’s granulomatosis: does it occur as persistent disease stage?” Annals of the Rheumatic Diseases, vol. 69, no. 11, pp. 1934–1939, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Csernok, A. Trabandt, A. Müller et al., “Cytokine profiles in Wegener’s granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation,” Arthritis & Rheumatism, vol. 42, no. 4, pp. 742–750, 1999. View at Publisher · View at Google Scholar
  16. F. De Geeter and P. Gykiere, “(18)F-FDG PET imaging of granulomatosis with polyangiitis-Wegener’s syndrome,” Hellenic Journal of Nuclear Medicine, vol. 19, no. 1, pp. 53–56, 2015. View at Google Scholar
  17. M. Soussan, N. Abisror, S. Abad et al., “FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review,” Autoimmunity Reviews, vol. 13, no. 2, pp. 125–131, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Khan, C. A. Lawson, M. A. Quinn, A. H. Isdale, and M. J. Green, “Successful treatment of anca-negative Wegener’s granulomatosis with rituximab,” International Journal of Rheumatology, vol. 2010, Article ID 846063, 2 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Ooka, A. Maeda, H. Ito, M. Omata, H. Yamada, and S. Ozaki, “Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener’s granulomatosis: a case report,” Modern Rheumatology, vol. 19, no. 1, pp. 80–83, 2009. View at Publisher · View at Google Scholar